Hemoteq competitive analysis

Explore patent oppositions filed by Hemoteq against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 10, 2026
Patent NumberTitleApplicantOpposition Date
Long-Acting Limus Formulation On Balloon CathetersINNORAApr 22, 2021
Medical Device For Dispensing MedicamentsBAYERMay 22, 2019
Bolloon Catheter For Paclitaxel-ReleaseBAYERAug 8, 2018
Medical Device For Dispensing MedicamentsBAYERApr 25, 2018
Angioplasty Balloons Drug-Coated In An Expanded ConditionCOOK INCORPORATEDMar 18, 2015
Angioplasty Balloons Drug-Coated In An Expanded ConditionCOOK INCORPORATEDMar 18, 2015

Explore Hemoteq's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
May 27, 2015Device And Method For Eliminating Biologically Harmful Substances From Bodily Fluids1

Latest PTAB cases involving Hemoteq

Discover the latest PTAB cases involving Hemoteq, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hemoteq with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HEMOTEQ61 - -
BAYER42133 - -
COOK INCORPORATED - 135 -
COOK MEDICAL27261 -